Constantine Chinoporos
Chief Operating Officer chez APPLIED THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Constantine Chinoporos is currently the Chief Operating & Business Officer at Applied Therapeutics, Inc. Prior to this, he was the Chief Business Officer at Boston Pharmaceuticals, Inc. from 2015 to 2021 and then at Albireo Pharma, Inc. from 2021 to 2023.
He received his undergraduate degree and MBA from Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/12/2023 | 300 000 ( 0,28% ) | 2 M $ | 31/03/2024 |
Postes actifs de Constantine Chinoporos
| Sociétés | Poste | Début |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Operating Officer | 28/12/2023 |
Anciens postes connus de Constantine Chinoporos
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01/03/2023 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2021 |
Formation de Constantine Chinoporos
| Cornell University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APPLIED THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
